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for influenza vaccination, ILI symptoms, time off work/education, and HCRU. 
Transmission of ILI from children to adults was estimated. Descriptive statistics 
were used. Results: Across 938 participants/households there were 1895 adults 
mean age 40.6 years, 52.7% females; 1695 children mean age 8.7 years, 46.8% females. 
91/306 adult ILI incidences were related to a child ILI (29.7%, 95%CI:26.5%-33.0%). 69 
of these (75.8%, 95%CI:60.3%-91.3%) had symptom duration> 3 days, 31/86 employed 
(36.0%; 95%CI:28.5%-43.6%) reported taking time off work with 22/31 (71.0%; 
95%CI:46.2%-95.8%) taking ≥ 2 days off. 13/91 (14.3%; 95%CI:11.5%-17.1%) had general 
practice (GP) visits, 5/91 (5.5%; 95%CI:4.5%-6.5%) had GP telephone consultations, 
6/91 (6.6%; 95%CI:5.3%-7.8%) received prescriptions, 76/91 (83.5%; 95%CI:66.5-100.6%) 
used over the counter (OTC) medications because of their ILI. 67 adults reported time 
off because of child ILIs (310 incidences); 30/67 (44.8%; 95%CI:34.2%-55.4%) taking 
≥ 2 days. This represents 67 adults/152 working adults (44.1%; 95%CI:37.2%-51.0%) 
in the child ILI households. 180/310 (58.1%; 95%CI:51.7%-64.5%) of total child ILIs 
had time off education, 81/180 (45.0%; 95%CI:38.5%-51.5%%) taking ≥ 3 days. 59/310 
(19.0%; 95%CI:17.0%-21.1%) had GP visits, 22/310 (7.1%; 95%CI:6.4%-7.8%) had GP 
telephone consultations, 48/310 (15.5%; 95%CI:13.8%-17.2%) received prescriptions, 
234/310 (75.5%; 95%CI:67.1-83.8%) used OTC medications. ConClusions: Based 
on survey, approximately 1/3 of adult ILIs were related to prior household child 
ILI. ILI in a household often required absence from work and ILI in children often 
resulted in time off education. GP visits were the most frequent burden to the 
National Health Service.
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CoPINg wIth methICIllIN resIstaNt staPhyloCoCCus aureus (mrsa) IN 
germaN rehabIlItatIoN CeNters – are the INCeNtIves aPProPrIate?
Claus F., Ried W.
University of Greifswald, Greifswald, Germany
objeCtives: Patients colonized with multidrug-resistant organisms, especially 
Methicillin resistant Staphylococcus aureus (MRSA), impose a risk on other 
patients and on health care professionals. In addition, they will suffer from sub-
stantial health problems when getting an infection. This contribution examines 
the incentives of German rehabilitation centers to implement screening strategies 
to stem nosocomial infections and the spread of MRSA. Methods: Relying on a 
decision tree analysis, the expected health care cost per capita is calculated for 
three strategies: (i) general screening, (ii) risk-based screening, both on admission, 
and (iii) no screening at all. Parameters are taken from the published literature. 
To handle uncertainty, multivariate sensitivity analyses are performed. Results: 
From the perspective of a rehabilitation center, the third strategy yields the lowest 
expected cost while the first one causes the highest cost. This ordering is robust with 
respect to sensitivity analysis. Thus, cost savings due to a lower number of MRSA 
infections are not sufficient to offset the cost of the test and further prevention 
measures applied to individuals with a positive result. ConClusions: In Germany, 
rehabilitation centers are reimbursed by daily rates. In particular, they receive no 
extra fees for prevention measures. As our analysis demonstrates, this implies the 
incentive to implement MRSA screening to be too weak. Hence, MRSA prevention 
measures that would be beneficial to society will not be undertaken. However, our 
results can be used to indicate changes in the remuneration system that would 
provide rehabilitation centers with an appropriate incentive for MRSA prevention. 
Moreover, hygiene regulations enacted very recently (MedHygVO), in the light of 
our analysis, can be interpreted in a similar manner due to the requirement of a 
stricter hygiene regimen.
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estImatINg the DIreCt meDICal Cost, leNgth of stay aND ImPaCt of 
reImbursemeNt ChaNge oN health Care assoCIateD INfeCtIoNs
Singh R.R., Lawson K.A.
The University of Texas at Austin, Austin, TX, USA
objeCtives: In 2008, the Centers for Medicare and Medicaid Services discontin-
ued reimbursement for health care associated infections (HAIs) not reported to be 
present-on-admission (POA). The study objectives were to examine: (1) the impact 
of this reimbursement change on hospital-level HAI rates; and (2) the differences 
in total direct medical costs and length of stay (LOS) between patients with HAI 
(cases) and without HAI (controls). Methods: We conducted a retrospective, 
interrupted time series analysis using the Nationwide Inpatient Sample obtained 
from the Health care Cost and Utilization Project database for years 2006 to 2010. 
The primary outcome was diagnosis of HAI, identified based on ICD-9-CM codes 
for sepsis, pneumonia, surgical site infections, catheter-associated urinary tract 
infections or blood stream infections from a pool of “at-risk” patients defined as ≥ 
18 years of age, without a diagnosis of cancer, HIV/AIDS or immunocompromised 
condition. Patients with an LOS ≤ 2 days were excluded to avoid inclusion of patients 
with pre-existing infections. Differences in total direct medical costs and LOS of 
propensity score-matched cases and controls were assessed using Wilcoxon signed-
rank tests. Results: The HAI rate was higher in the “at-risk” population (12.95 vs. 
2.83 per 100 admissions) than in the total inpatient population, ≥ 18 years of age. 
Discontinuation of reimbursement for HAI was associated with a 0.37 point (-0.375, 
p = 0.0064) decrease in HAI rate per 100 admissions for “at-risk” patients. Compared 
to controls, cases had significantly higher mean annual total direct medical costs 
($15,313 ± 17,470 vs. $21,561 ± 31,718, p< 0.0001) and a higher mean LOS (7.1 ± 6.5 
vs. 10.2 ± 11.3 days, p< 0.0001). ConClusions: Total direct medical costs and LOS 
are higher for patients with HAI compared to those without HAI. Policy changes in 
the reimbursement of HAI cases made in 2008 showed a reduction in the rate of 
HAIs in the “at-risk” population.
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evaluatIoN of the effeCtIveNess of ImPlemeNtINg aN aNtImICrobIal 
stewarDshIP Program IN a meDICal CeNter IN taIwaN
Huang L., Kuo C., Lin Y., Chen Y., Wong Y., Lin Y.
Wang Fang Hospital, School of Pharmacy Taipei Medical University, Taipei, Taiwan
varicella cases for 75% and 65% VE-D1 was respectively 73.9%/71.3% by year 30 and 
65.0%/61.6% by year 80. When coverage was 75%/60%, the reduction in number of 
varicella cases was 60.2%/58.1% by year 30 and 55.0%/52.5% by year 80 for VE-D1 of 
75% and 65%, respectively. ConClusions: The coverage of varicella vaccination is 
an important factor affecting the number of varicella cases when long term interval 
between two doses is considered. This is a more influential factor on predicted cases 
than the first dose efficacy.
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herPes Zoster-relateD health Care resourCe utIlIZatIoN IN CaNCer 
PatIeNts IN 5 euroPeaN CouNtrIes
Gebremeskel B.G.1, Lopez-Gonzalez L.2, Patwardhan P.3, Chin J.4, Schwalm M.S.4, Acosta C.J.3, 
Margolis J.M.5
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TX, USA, 3Merck & Co., Inc, West Point, PA, USA, 4Cegedim Strategic Data, Jersey City, NJ, USA, 
5Truven Health Analytics, Bala Cynwyd, PA, USA
objeCtives: To examine herpes zoster-related health care resource utilization in 
hematologic (HM) or solid tumor malignancy (STM) patients seeking care at pri-
mary-care practices in 5 European countries. Methods: Longitudinal primary-
care EMR databases (Cegedim Strategic Data) in France, Italy, Germany, Spain, and 
United Kingdom (UK) were analyzed retrospectively (2007-2012). Patients with HM 
or STM diagnoses were followed for a subsequent first herpes zoster (HZ) diagno-
sis (index event). HZ patients were matched with non-HZ (HM and STM) patients 
using propensity scores based on demographics and relevant clinical characteris-
tics. Patients were observed for 6 months pre-index (baseline) and 6 months post-
index. Demographics, comorbidities, pharmacotherapy, and health care resource 
utilization (office visits, specialty referrals, laboratory tests, and prescriptions) were 
reported with statistical significance set at p≤ 0.05. Results: HZ patients meeting 
selection criteria across all 5 countries included 907 HM and 4317 STM. Mean ages 
ranged 64.8±15.5 (Italy-HM) to 71.8±11.5 (France-STM); female gender varied for HM 
from 49% (UK) to 58% (Germany), and STM 56% (UK) to 63% (France). Case and control 
populations were well balanced at baseline. Office visits per patient were signifi-
cantly higher post-index for HZ cohorts across all countries and malignancy types 
(except Spain HM), ranging from 0.5 more visits (Spain-STM, p= 0.009,) to 2.8 more 
(UK-HM, p< 0.001). Significantly more HZ patients had post-index specialty referrals 
(France-STM, 2.6% more, p= 0.05; Germany-STM, 4.8% more, p= 0.012), and signifi-
cantly more HZ patients received prescriptions post-index in all cohorts across all 
countries, varying from 19.2% more patients (Spain-STM, p< 0.001,) to 47.3% (UK-HM, 
p< 0.001). Significantly more HZ patients received laboratory testing, ranging from 
3.2% more patients (Italy-STM, p= 0.006,) to 11.4% (UK-HM, p= 0.003). ConClusions: 
Significantly higher health care resource use was incurred by HZ-afflicted HM and 
STM patients within 6 months of HZ diagnosis for office visits, specialty referrals, 
laboratory testing, and outpatient prescribing compared with matched controls 
across 5 European countries.
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use of hosPItal servICes by hIv PatIeNts, 2012
Brennan A.1, Jackson A.2, Browne J.P.1, Bergin C.3, Horgan M.1
1University College Cork, Cork, Ireland, 2Cork University Hospital, Cork, Ireland, 3St James 
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objeCtives: Information on the pattern of health services use by HIV patients is 
required to effectively plan services, particularly in light of increasing non-infec-
tious chronic diseases in this population. This study examined the use of inpatient, 
outpatient, and emergency department (ED) services by HIV positive patients who 
attended Cork University Hospital (CUH) for HIV care in 2012. Methods: All pub-
lic HIV patients who attended CUH for inpatient or outpatient care in 2012 were 
identified using an existing clinical database. Data on outpatient appointments 
by speciality (excluding dialysis), ED visits and inpatient episodes were extracted 
from the hospital information system. Patients with no attendance between Jul-
Dec were censored at the month of last visit. Results: Data were extracted on 
328 patients (3642 patient-months), 1434 outpatient visits (1180 Infectious Disease 
(ID), 254 other), 100 ED visits (58 patients) and 74 inpatient episodes (51 patients). 
Patients had a median of 3 ID outpatient visits (range 0-12), 26% of patients also 
attended other outpatient specialties (median 2, range 1-22). On multivariate 
analysis being more recently diagnosed, and being on ART but not suppressed, or 
starting/stopping ART in 2012 were associated with increased outpatient ID visits, 
while age > 50 years was associated with fewer outpatient ID visits. Those diag-
nosed 2003-2007 and 2008-2011 had significantly more outpatient non-ID visits 
while late diagnosis was associated with fewer non-ID visits. Use of ED services 
was positively associated with unknown risk factor and being diagnosed in 2012. 
Use of inpatient services was positively associated with diagnosis in 2012 and 
negatively associated with a minimum CD4 count ≥ 350 cells/μ l. ConClusions: 
These data provide baseline information on the utilisation rates of ID and other 
specialities by HIV positive patients. Such data are useful for identifying factors 
which could be targeted for quality improvement interventions as well as for 
estimating future service requirements.
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the ImPaCt of INflueNZa lIke IllNess (IlI) IN ChIlDreN oN workINg 
aDults
Blak B.T.1, Wade A.G.2, Crawford G.2, Emmas C.1, Lichfield J.1
1AstraZeneca UK Ltd, Luton, UK, 2Patients Direct, Glasgow, UK
objeCtives: To evaluate the impact of child ILI on working adults’ health, pro-
ductivity and health care resource use (HCRU); and to evaluate ILI’s impact on the 
children. Methods: Participants ≥ 18 years, full or part time working and with 
minimum one child ≤ 17 years residing in household were recruited nationally 
(UK) for this online survey between October 2012 and May 2013. Demographics, 
employment status, morbidities and influenza vaccination history were collected 
for all household members. During follow-up, households were surveyed fortnightly 
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CorreCtIve estImatIoN of New Cases of hePatItIs C INfeCtIoNs IN 
ChINa betweeN 2005 aND 2013
Feng G.S.1, Wang J.F.2, Wei L.3, Yu S.C.1, Kong L.C.2, Xu C.D.2, Hu M.G.2, Liao J.Q.1, Chu F.J.4, Hu Y.H.1, 
Guo Y.1, Sun H.Q.1, Ma J.Q.1, Wang Y1
1Chinese Center for Disease Control and Prevention, Beijing, China, 2Institute of Geographic 
Sciences and Natural Resources Research, Beijing, China, 3Peking University People’s Hospital, 
Beijing, China, 4Donggang Center for Disease Control and Prevention, Liaoning, China
objeCtives: Hepatitis C Virus (HCV) infection is a significant public health issue 
in China. In 2006, a national seroepidemiological survey of HCV showed 5.6 million 
people were tested with HCV positive. Although new cases with HCV infection 
are mandatory to report in China, it is believed that the reported information is 
under-reported. The objective of this study was to correctively estimate newly 
infected HCV cases by gender, age, and province in China from 2005 to 
2013. Methods: The Back-calculation method was used to estimate the initial 
number of HCV infection, based on annual HCV reported cases issued by China 
CDC and the incubation distribution of HCV, which was from an outbreak due to 
a medical accident at a county in Liaoning, China in 2012; then the Expectation 
Maximization (EM) algorithm was employed to obtain the optimization estima-
tion of HCV infection. Prior to the estimation, a rate of 49.7% from Denniston’s 
study, in which subjects were not aware that they were infected with HCV was 
considered in the calculation to control for the missing report. The Monte Carlo 
simulation was applied to calculate total numbers and their 95% CIs. Results: 
The estimated numbers of newly-infected HCV cases from 2005 to 2013 were 
nearly 3.4 million. While 57.8% of the estimated newly-infected cases were 
male, cases of 30 to 39 years old were the group with the highest newly-infected 
cases of HCV (n= 963, 304, 28.4%). The estimated newly-infected cases also showed 
geographic variations that north, southwest, and west were among the regions 
where higher numbers were found. ConClusions: This is the first time to 
correctively estimate newly-infected HCV cases using the annual infection dis-
ease report of China CDC; however, this estimation may still be underestimated 
because of the low unawareness of HCV and high rate of missing report on HCV 
cases in China.
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PeDIatrICIaN’s PersPeCtIve oN PNeumoCoCCal CoNjugate vaCCINes IN 
INDIa: aN exPloratory stuDy
Zodpey S.1, Farooqui H.H.1, Chokshi M.2
1Public Health Foundation of India, Gurgaon, India, 2Public Health Foundation of India, New Delhi, 
India
objeCtives: - This paper focuses on this knowledge gaps for informed decision-
making and identifies key barriers in uptake PCV in India. Methods: - Qualitative 
interviews were conducted with pediatricians registered with Indian Academy of 
Pediatrics to generate evidence on perspective and practices regarding the PCV. 
A multi-level stratified sampling was applied to identify pediatricians across 12 
metropolitan cities. The analysis was conducted using standard qualitative tech-
niques to identify key domains, words, phrases and concepts from respondents. 
Quantitative variables are reported as mean and proportions. Results: -Majority 
(67.7%) of pediatricians advice for PCV to all whereas 32.2% advice PCV only to 
those who can afford. Around half (50.8%) have no specific preference and rec-
ommend any PCV vaccine where as 28.0% recommend PCV13. Main reason for 
acceptance of PCV were educated and informed clients (50.8%) followed by pedia-
trician’s advice and counseling (25.4%) whereas main reason for denial was price 
of vaccine (97.3). In addition, majority (74.1%) of pediatricians wanted PCV to be 
included into UIP whereas (17.7%) didn’t and (8.0%) were not sure. ConClusions: 
- Pediatricians should put efforts to increase awareness about vaccine prevent-
able disease among their clients and can facilitate bridge the knowledge action 
gap by helping their clients to make informed decision with regards to uptake of 
newer vaccines.
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the stuDy oN the PresCrIbINg PatterN of aCINetobaCter INfeCtIoN IN 
a tertIary Care hosPItal
Vilakkathala R.1, Sudhapalli V.2, Kanad D.3, Mallayasamy S.1
1Manipal University, Manipal, India, 2Manipal College of Pharmaceutical Sciences, Manipal 
University, Manipal, Karnataka, India, 3Manipal College of Pharmaceutical Sciences, Manipal 
University, Manipal, Karnataka, India
objeCtives: Acinetobacter genuses of bacteria have become a challenge for every 
hospital with regards to its treatment and cost of therapy due to its penchant to 
acquire resistance. The aim of the present study was to ascertain the prescribing 
pattern of antibiotics in Acinetobacter infection. Methods: A cross sectional, 
observational, retrospective study was carried out, over a period of 6 months in 
a tertiary care hospital. The data collected was analysed to understand the pat-
tern with respect to patient demographics, prescription patterns, co-morbidities 
as risk factors to infection, and resistance patterns. Results: The study results 
showed that male patients had greater risk for A. baumannii infections with an 
age group of 41-60 years. The length of stay of a patient of A. baumanni infec-
tion was 23.51±27.97 days. The bacteria were found to be resistant to almost 
all categories of drugs. Based on the study of prescription of antibiotics it was 
found that empirical antibiotic therapy was prescribed to most patients. with the 
most prescribed drug being tigecycline and cefixime in 47 (97.9%) patients. The 
least prescribed antibiotic was Piperacillin – Tazobactam prescribed to 25 (42.9%) 
patients. Cefoperazone-sulbactam was found to have an antibiotic action against 
the bacterium. ConClusions: The study concluded that male patients were at 
a greater risk of A. baumannii infections. Length of stay of patients was on aver-
age 23.51±27.97 days. The study showed tigecycline and cefixime were the most 
prominently used antibiotic. The strain in this study was resistant to almost all 
cephalosporins except Cefoperazone-Sulbactam which had activity in 57.14% of 
the samples tested.
objeCtives: To evaluate the effectiveness of an antimicrobial stewardship pro-
grams. Methods: The antimicrobial stewardship program was started since 
November 1, 2012, and pharmacists would intervene when antimicrobial agents, 
including levofloxacin, teicoplanin, meropenem, tigecycline and piperacillin/tazo-
bactam, were used for more than 7 days. Inpatients who previously received any 
one of the 5 agents from 2011/11/1 to 2012/10/31 (phase 1) and from 2012/11/1 to 
2013/10/31 (phase 2) were included. Patients’ personal data, indication, residency, 
surgery history, duration of therapy, duration of hospital stay, quantity of antibi-
otics use and the cost of antibiotics were collected. The primary outcome was to 
compare the amount of antibiotics usage in defined daily doses (DDD per 1000 
patient-days) between the 2 phases. Secondary outcomes were to compare the 
duration of therapy, the proportion of patients having prolonged antibiotic use over 
14 days, the duration of hospital stay, expense of antibiotics, and readmission rate 
in 30 days. Results: A total of 8,781 patients were included. 4,571 patients were 
in phase 1 and 4,210 were in phase 2. The most prevalent indications for antibiotic 
use were pneumonia and urine tract infection. The total quantity of antibiotics in 
phase 2 was significantly decreased from 224.08 DDD to 188.89 DDD as comparing 
with phase 1. The DDDs of each agent in phase 2 were also significantly decreased 
respectively. After the program implementation, the expense of antibiotics, duration 
of therapy, proportion of patients having prolonged antibiotic use over 14 days and 
duration of hospital stay were all significantly decreased. The readmission rate in 
30 days did not differ between the two phases. ConClusions: The implementa-
tion of antimicrobial stewardship program was effective in reducing the amounts 
of antibiotics usage, and it may reduce the inappropriate use of antibiotics, shorten 
the duration of therapy and save medical expense without affecting quality of care 
in term of readmission rate.
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are aNtIbIotIC PolICIes aND reImbursemeNt DeCIsIoNs alIgNeD?
Schey C.1, Connolly M.2
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objeCtives: According to the World Health Organisation, the emergence of resist-
ant organisms has rendered antibiotics ineffective in some settings (1). In an 
attempt to address current and future unmet needs in this area innovative anti-
biotics are being developed. We conducted a review of recent HTA evaluations for 
antibiotics to investigate whether policy initiatives to promote advances in antibiot-
ics are reflected in reimbursement decisions. Methods: The guidance directories 
of the Scottish Medicines Consortium (SMC), All Wales Medicines Strategy Group 
(AWMSG) and the National Institute for Health and Care Excellence (NICE) were 
reviewed for assessments of antibiotics, from 2000 until May 2014. Data relating to 
each assessment were extracted. A simple scoring system for the reimbursement 
decisions by the SMC and AWMSG was adopted: where a “positive” reimburse-
ment decision scored 3, “Restricted use” scored 1, “Not yet reviewed” scored 0 and 
“Rejected” scored -1. Results were plotted to show the positioning of reimbursement 
decisions of AWMSG in relation to SMC. Results: A total of 18 antibiotics were 
identified as having been assessed by either SMC or AWMSG. Of these 18 products, 
only 2 were assessed by NICE, and a further 2 were the subjects of “Evidence Review 
Summaries”, product overviews that are not legally binding. Of the 18 antibiotics 
identified, only 3 and 2 received “Positive” reimbursement decisions by the SMC 
and AWMSG, respectively. Four antibiotics were “Not Recommended” by both SMC 
and AWMSG, of which several rejections were due to pharmaceutical companies 
not submitting dossiers to the regulatory body. Scatterplots of SMC and AWMSG 
scores featured six antibiotics in the top right quadrant. ConClusions: This study 
demonstrates the different assessment approaches by each regulatory body for 
antibiotics. Moreover, the low number of antibiotics reviewed highlights that the 
dearth of new, innovative antibiotics are not in keeping with policies to develop 
innovative antibiotics.
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aNalyses oN temPoral aND sPatIal ClusterINg aND ChaNgINg treND 
of hCv IN maINlaND of ChINa
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objeCtives: Analyzing population distribution, temporal and spatial clustering, 
and changing trend of Hepatitis C Virus（HCV（ in order to provide the evidence-based 
decision making for the control and prevention of HCV. Methods: HCV cases were 
extracted from the National Diseases Reporting System of China CDC between 2008 
and 2013. Spatial scanning unit was 2886 districts/counties in mainland China; 
temporal scanning unit was month, and time span was from Jan 2008 to Dec 2013. 
Kulldorff scan statistic was applied, and analyses were conducted by SaTScanTM 9.1. 
Making maps and visualizing results were carried out with ArcGIS 10.1. Results: 
Monitoring data of HCV from 2008 to 2013 demonstrated that most cases of HCV 
occurred between 30 to 59 years old, above 60%; males were more than females, 
the ratio of males to females was 1.20-1.35; the percentage of peasants was nearly 
60%. Results from SaTScan illustrated that the temporal and spatial clustering was 
existed for HCV; temporal dimension of HCV occurrence was from June to October 
of each year; spatial dimension was located in north-east area and north-west area. 
With respect to the changes of temporal and spatial clustering, class 1 clustering 
area was always located in the Middle of China. In 2011, it expended to the west 
half of China. Class 2 clustering area was stable and located in north-west of China, 
except for 2012. Class 3 clustering area was located in north-east of China, but it 
became smaller in 2013. Class 4 and 5 clustering area was located in south of China, 
and it became larger with time. ConClusions: Temporal and spatial clustering 
area of HCV was presented in this report, and its own changing pattern of clustering 
areas with years was noted. Findings from this paper will provide evidence-based 
decision making to prevent HCV infection, guide stockages and allocations of health 
resources, and to formulate HCV prevention and control strategies.
